Steven James
Member Board of Directors @Ventus Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Member Board of Directors @Ventus Therapeutics
EDUCATION
Brown University
BA, Biology
Northwestern University - Kellogg School of Management
MBA, Hospital and Health Administration
ABOUT STEVEN JAMES
CEO with over 35 years of pharma and biotech experience. Generated over $2B in M&A and deal value for investors and shareholders as CEO of Labrys Biologics, KAI Pharmaceuticals, and Pionyr Immunotherapeutics. Numerous board seats:Allakos, Inc. 2015-presentChrono Therapeutics 20••••19Ocera, lead independent director 20••••19) acquired by MallinkrodtCascadian Therapeutics 20••••18 (acquired by SeaGen)Antiva Biosciences, Chair 20••••23Soteria Biotherapeutics Chair, 2020 to 2022Ventus Therapeutics (2020 to present)Lyterian Therapeutics (2023 to present)Juvena Therapeutics (2024 to present)Rondo Therapeutics (2024 to present)Middlebridge School Board of Trustees, trustee emeritus,Narragansett, RIFounder, Neurodiverse Student Success Fund, St. Mary\'s College of CaliforniaBiotech advisory -James BioAdvisors, LLCPast member of Locust Walk Partners advisory board
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.